Brief: Adcock Ingram Says Natco Pharma To Buy All Eligible Shares Of Adcock Ingram
23/07/2025 11:44
July 23 (Reuters) - Adcock Ingram Holdings Ltd AIPJ.J: JSE: AIP - JOINT FIRM INTENTION ANNOUNCEMENT: OFFER BY NATCO PHARMA, DELISTING OF ADCOCK INGRAM AND WITHDRAWAL OF CAUTIONARY ADCOCK INGRAM HOLDINGS LTD - NATCO PHARMA TO BUY ALL ELIGIBLE SHARES OF ADCOCK INGRAM ADCOCK INGRAM HOLDINGS LTD - CASH CONSIDERATION OF ZAR75.00 PER SHARE FOR ADCOCK INGRAM ADCOCK INGRAM HOLDINGS LTD - CO'S ORDINARY SHARES TO BE DELISTED FROM JSE MAIN BOARD Source text: ID:nJseW0054a Further company coverage: AIPJ.J ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees